Medtech Start-Ups: Inflammatix, Immertec, Novoic, CardioMech & more

Posted by Life Science Intelligence on Aug 20, 2020 8:30:00 AM
Find me on:

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Novel molecular diagnostics for the detection of acute infections and sepsis from Inflammatix

Using proprietary machine learning algorithms, Inflammatix’s HostDx InSep and HostDx Fever are rapid point-of-care tests capable of producing results in 30 minutes or less. Inflammatix has successfully raised an estimated $33M in funding since its founding in 2016. Key competitors in the point of care diagnostics market include Abbott, BD, and Roche.

Start a Free Trial to Medtech Start-Up Tracker Today

Immertec, a VR training platform for surgeons, raises $6M in Series A funding round

The funds will be used to bring on key personnel, including a COO and supply chain manager. Interest in the company’s medical training platform has exploded as a result of the coronavirus pandemic. Using the technology, surgeons can learn new procedures and train with new medical devices. The company is planning to complete a larger Series B round in 2021.

Molecular Diagnostics, VR Training, & AI Speech Analytics Startups in Medtech

Novoic is identifying neurological disease with an AI-powered speech analytics platform

Novoic’s technology is capable of detecting alterations in speech patterns which can be early indicators of neurological disease. The company recently raised $2.6M in a late-July Seed round. Funds will be used to help the company build its research team and advance clinical programs. Novoic is currently seeking academic and commercial partnerships.

Catheter-based mitral valve repair technology is being developed by CardioMech

The mitral valve repair technology is intended to treat patients with severe, symptomatic degenerative mitral valve regurgitation caused by flail or prolapse. The company recently raised $18.5M in a Series A round, bringing the total amount raised by CardioMech to $23.5M. The transcatheter heart valve repair market has exploded in recent years, with strategics Abbott, Boston Scientific, Edwards, and Medtronic leading the market.

Alydia Health raises $13.9M in Series C funding round

The company is preparing for commercialization of its postpartum hemorrhage device in the US. Alydia Health has already submitted for 510(k) clearance from the FDA for its Jada system. To date the company has raised $24.2M in funding. Key competitors in the strategic landscape include Boston Scientific, Medtronic, and Teleflex.

Trobix Bio is using a phage-based biotechnology platform to fight against antimicrobial resistance

The company’s proprietary phage-based antibiotic sensitizing solutions, GoTraP and ActiSense offer a highly selective approach to circumventing bacteria resistance for commonly used antibiotics. The company recently raised $3M in a Series A round.

Fractyl Laboratories is developing minimally invasive therapies to treat metabolic disease

In June the company was granted Investigational Device Exemption from the FDA in order to begin a pivotal study of its Revita DMR device for the treatment of insulin resistance in individuals with Type 2 Diabetes. To date, the company has raised $190.1M in funding, with a recently completed Series E round valued at $55M.

Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Start-Up Tracker.

Topics: Startup, Strategics, Medtech, Medtech Innovation Weekly Update, Medtech Unicorn

Stay connected with our latest posts:

About the Author

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.

Contact LSI here, via phone 714 847 3540, or email info@lsintel.com